Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Use of Export in Primary Percutaneous Coronary Intervention

NCT: NCT05510661 · ACTIVE_NOT_RECRUITING

NCT IDNCT05510661
StatusACTIVE_NOT_RECRUITING
Start Date2024-01-15
Completion2026-05-31

Brief Summary

Aim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.

Frequently Asked Questions

What is Use of Export in Primary Percutaneous Coronary Intervention?

Use of Export in Primary Percutaneous Coronary Intervention is a clinical trial registered under NCT05510661. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05510661?

The current status of NCT05510661 (Use of Export in Primary Percutaneous Coronary Intervention) is: ACTIVE_NOT_RECRUITING.

When did Use of Export in Primary Percutaneous Coronary Intervention start?

Use of Export in Primary Percutaneous Coronary Intervention started on 2024-01-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑